GET THE PREMIUM SUBSCRIPTION FREE FOR 14 DAYS!

Acceleron Pharma Inc. Stock Price (Quote) NASDAQ:XLRN

$128.24 ( 0.72% ) Friday, 18th Jun 2021

Range Low Price High Price Comment
30 days $121.33 $135.06 Friday, 18th Jun 2021 XLRN stock ended at $128.24. This is 0.72% more than the trading day before Thursday, 17th Jun 2021. During the day the stock fluctuated 3.09% from a day low at $125.13 to a day high of $129.00.
90 days $111.75 $146.15
52 weeks $85.58 $146.15

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
2021-06-18 $126.37 $129.00 $125.13 $128.24 578 708
2021-06-17 $126.87 $128.28 $125.44 $127.32 174 311
2021-06-16 $128.84 $129.87 $125.92 $126.74 153 253
2021-06-15 $130.32 $130.96 $127.16 $128.71 240 745
2021-06-14 $133.85 $135.06 $130.15 $131.06 248 150
2021-06-11 $131.48 $133.60 $130.87 $133.44 243 139
2021-06-10 $126.78 $131.10 $125.95 $130.87 240 806
2021-06-09 $125.00 $127.55 $124.54 $126.51 147 049
2021-06-08 $127.96 $127.96 $123.66 $125.14 148 648
2021-06-07 $124.49 $128.08 $124.00 $126.69 348 966
2021-06-04 $124.30 $125.56 $122.00 $124.52 258 421
2021-06-03 $123.41 $125.01 $122.28 $123.18 203 801
2021-06-02 $130.45 $130.47 $123.63 $124.20 475 997
2021-06-01 $131.13 $131.13 $127.33 $130.26 315 858
2021-05-28 $131.12 $134.39 $130.30 $130.89 207 291
2021-05-27 $131.69 $132.36 $129.68 $130.41 308 177
2021-05-26 $131.36 $132.66 $129.94 $131.81 247 904
2021-05-25 $130.60 $130.99 $128.72 $130.16 245 837
2021-05-24 $130.94 $131.78 $129.87 $130.28 344 376
2021-05-21 $127.53 $131.81 $127.53 $129.68 306 667
2021-05-20 $124.95 $130.62 $124.86 $127.39 243 557
2021-05-19 $122.83 $125.63 $121.33 $123.68 267 750
2021-05-18 $126.79 $128.71 $124.03 $124.38 354 600
2021-05-17 $125.04 $127.11 $124.13 $126.10 221 876
2021-05-14 $123.72 $126.95 $122.79 $126.09 262 488
2021-05-13 $121.69 $125.37 $120.86 $123.32 395 605
2021-05-12 $119.20 $122.80 $118.11 $121.17 330 892
2021-05-11 $113.10 $121.92 $111.75 $120.32 271 952
2021-05-10 $117.72 $117.72 $115.20 $116.50 239 082
2021-05-07 $122.28 $123.10 $117.38 $118.18 468 955
2021-05-06 $121.53 $122.04 $118.68 $121.83 371 332
2021-05-05 $120.59 $122.78 $119.37 $121.45 369 746
2021-05-04 $123.84 $125.00 $119.58 $120.05 448 292
2021-05-03 $124.74 $126.56 $123.55 $124.74 217 539
2021-04-30 $125.52 $127.48 $124.31 $124.97 430 414
2021-04-29 $126.24 $127.56 $124.61 $125.46 192 792
2021-04-28 $123.77 $129.85 $123.12 $126.95 369 363
2021-04-27 $127.49 $128.99 $124.00 $124.51 615 290
2021-04-26 $123.04 $127.02 $122.15 $126.67 215 602
2021-04-23 $123.34 $123.86 $120.10 $122.13 348 231
2021-04-22 $121.70 $123.43 $119.92 $122.30 335 859
2021-04-21 $120.20 $123.20 $118.42 $123.03 223 327
2021-04-20 $119.44 $121.74 $118.01 $120.11 557 904
2021-04-19 $121.30 $121.72 $117.81 $120.28 602 942
2021-04-16 $124.34 $124.38 $121.36 $122.05 236 090
2021-04-15 $123.65 $126.23 $122.90 $124.03 262 094
2021-04-14 $123.39 $127.00 $122.02 $122.37 354 340
2021-04-13 $123.25 $126.20 $119.76 $123.24 586 207
2021-04-12 $127.28 $128.20 $122.60 $123.08 596 353
2021-04-09 $129.88 $129.88 $124.95 $126.85 306 466

About Acceleron Pharma Inc.

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT